While there is no known cure for ALS, stem cell therapy holds great promise in treating this debilitating disease. In this article, we’ll explore how stem cell therapy works in treating diseases ...

Its lead product is NeuroNata-R (lenzumestrocel), the world’s first stem cell-based therapy for amyotrophic lateral sclerosis (ALS). NeuroNata-R was approved as an orphan drug for the treatment ...

Stem cells can be used either to replace dead ... The company has already shown that its MSC-NTFs are effective in animal models of ALS, Parkinson’s disease, multiple sclerosis, optic nerve ...

Amyotrophic lateral sclerosis (ALS) is a fast-progressing neurodegenerative disease with an average survival time of three years. In ALS, certain types of neurons called motor neurons that are ...

Notably, the investigators applied this new method to investigate the drug responses of sporadic ALS patients, as reported in Morimoto et al., Cell Stem Cell, 2023, and demonstrated a correlation ...

Ncardia’s iPSC-derived microglia may aid ALS research and help to screen new therapies that target inflammation in ALS.

After developing treatments for multiple sclerosis, he turned his focus to two main disease areas – diabetes and ALS. “Any tissue in the body can be made from the stem cells as they are ...

Complex biological mechanisms and unidentified therapeutic targets for amyotrophic lateral sclerosis (ALS ... Patient-derived induced pluripotent stem cell (iPSC) organoids have emerged as ...

ALS (Lou Gehrig’s disease) as well as neurodevelopmental and psychiatric disease. We are also interested in applications outside the CNS — particularly in musculoskeletal disease and disorders related ...

An FDA advisory committee has voted by a huge margin that BrainStorm’s stem cell therapy for amyotrophic lateral sclerosis (ALS) – NurOwn – does not have enough data to support its approval.